Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, EGFR-Mutant, Metastatic Nonsquamous Non-Small Cell Lung Cancer
KEYNOTE-789 III期研究:培美曲塞联合铂类药物,加或不加帕博利珠单抗治疗酪氨酸激酶抑制剂耐药、EGFR突变、转移性非鳞状非小细胞肺癌
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.23.02747
Yang, James Chih-Hsin; Lee, Dae Ho; Lee, Jong-Seok; Fan, Yun; de Marinis, Filippo; Iwama, Eiji; Inoue, Takako; Rodríguez-Cid, Jerónimo; Zhang, Li; Yang, Cheng-Ta; de la Mora Jimenez, Emmanuel; Zhou, Jianying; Pérol, Maurice; Lee, Ki Hyeong; Vicente, David; Ichihara, Eiki; Riely, Gregory J; Luo, Yiwen; Chirovsky, Diana; Pietanza, M Catherine; Bhagwati, Niyati; Lu, Shun